Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
10/11/2024 | $475.00 | Overweight | KeyBanc Capital Markets |
9/3/2024 | $427.00 | Equal-Weight | Morgan Stanley |
5/30/2024 | $396.00 | Outperform | Robert W. Baird |
3/6/2024 | $356.00 | Overweight | Barclays |
1/4/2024 | $277.00 → $301.00 | Outperform → Mkt Perform | Bernstein |
12/11/2023 | $271.00 | Buy → Neutral | Goldman |
4/21/2023 | $304.00 | Overweight | Cantor Fitzgerald |
4/19/2023 | $257.00 → $283.00 | Neutral | JP Morgan |
10-Q - HCA Healthcare, Inc. (0000860730) (Filer)
8-K - HCA Healthcare, Inc. (0000860730) (Filer)
8-K - HCA Healthcare, Inc. (0000860730) (Filer)
HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the third quarter ended September 30, 2024. Key third quarter metrics (all percentage changes compare 3Q 2024 to 3Q 2023 unless otherwise noted): Revenues totaled $17.487 billion Net income attributable to HCA Healthcare, Inc. totaled $1.270 billion, or $4.88 per diluted share (which includes an estimated $0.15 per diluted share unfavorable impact from Hurricane Helene) Adjusted EBITDA totaled $3.267 billion Cash flows from operating activities totaled $3.515 billion Same facility admissions increased 4.5 percent and same facility equivalent admissions increased 4.5 percent "Our people recently,
HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 3Q Earnings Release Call When: Friday, October 25, 2024 at 9:00 am central (10:00 am eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, [email protected] If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news/home/20240926343840
Raises 2024 Guidance HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the second quarter ended June 30, 2024. Key second quarter metrics (all percentage changes compare 2Q 2024 to 2Q 2023 unless otherwise noted): Revenues totaled $17.492 billion Net income attributable to HCA Healthcare, Inc. totaled $1.461 billion, or $5.53 per diluted share Adjusted EBITDA totaled $3.550 billion Cash flows from operating activities totaled $1.971 billion Same facility admissions increased 5.8 percent while same facility equivalent admissions increased 5.2 percent "The company's results for the second quarter were positive and reflected strong demand
HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the third quarter ended September 30, 2024. Key third quarter metrics (all percentage changes compare 3Q 2024 to 3Q 2023 unless otherwise noted): Revenues totaled $17.487 billion Net income attributable to HCA Healthcare, Inc. totaled $1.270 billion, or $4.88 per diluted share (which includes an estimated $0.15 per diluted share unfavorable impact from Hurricane Helene) Adjusted EBITDA totaled $3.267 billion Cash flows from operating activities totaled $3.515 billion Same facility admissions increased 4.5 percent and same facility equivalent admissions increased 4.5 percent "Our people recently,
HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced it will host its sixth annual "Crush the Crisis" national prescription drug take back day on Saturday, Oct. 26, 2024. This year, 133 HCA Healthcare facilities across the country will partner with local law enforcement to help communities safely and anonymously dispose of unused or expired medications. Held each year, in alignment with the Drug Enforcement Administration's (DEA) National Prescription Drug Take Back Day, HCA Healthcare holds "Crush the Crisis" events to raise awareness about the dangers of prescription drug misuse and the importance of proper disposal of unused or expired medic
HCA Healthcare, Inc. (NYSE:HCA), is scheduled to present at the following healthcare conferences: November 14, 2024 at 7:15am PT at the 2024 UBS Global Healthcare Conference at the Terranea Resort in Ranchos Palos Verdes, CA. November 20, 2024 at 11:20am ET at the 2024 Wolfe Research Healthcare Conference at the Wolfe Offices in New York, NY. November 21, 2024 at 8:00am CT at the 2024 Stephens Annual Investment Conference at the Grand Hyatt in Nashville, TN. A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the Company's website, www.hcahealthcare.com. Dates and times may be s
KeyBanc Capital Markets initiated coverage of HCA with a rating of Overweight and set a new price target of $475.00
Morgan Stanley initiated coverage of HCA with a rating of Equal-Weight and set a new price target of $427.00
Robert W. Baird initiated coverage of HCA with a rating of Outperform and set a new price target of $396.00
HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that the HCA Healthcare Foundation has helped Girl Scouts of the USA (GSUSA) launch a new series of Mental Wellness Patch Programs to address mental wellness among girls in 4th through 12th grade. This is a result of the HCA Healthcare Foundation's $1.38 million grant to GSUSA, through its Healthier Tomorrow Fund, which was announced last year. "The HCA Healthcare Foundation has a long history of partnering with Girl Scouts nationally and locally. We are proud to deepen our partnership with Girl Scouts on this research-based mental wellness program," said Joanne Pulles, vice president of com
HCA Healthcare, Inc. (NYSE:HCA) today announced Jyric Sims, Ph.D., will become president of the company's West Florida Division, effective June 12. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230420005364/en/Jyric Sims, Ph.D. (Photo: Business Wire) Sims, who currently is CEO of HCA Healthcare's Medical City Plano and Medical City Frisco hospitals, will succeed Ravi Chari, M.D., who recently announced he will retire after 15 years with the company to pursue opportunities in early-stage healthcare companies. A more than 20-year healthcare veteran, Sims has been with HCA Healthcare since 2011. He has served as chief executive
HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that Chuck Hall, HCA Healthcare's National Group president, will retire at the end of the year after nearly 36 years with the organization. Currently, Hall is responsible for HCA Healthcare's operations at 96 hospitals across 13 states. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220817005233/en/HCA Healthcare Announces Retirement of Longtime Senior Executive Chuck Hall (Photo: Business Wire) Over more than three decades, Hall has been influential in many successful initiatives that will benefit the company for years to come, inc
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)
SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)
SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Baird increased Apple Inc. (NASDAQ:AAPL) price target from $200 to $240. Baird analyst William Power maintained an Outperform rating. Apple shares fell 0.1% to trade at $218.51 on Thursday. See how other analysts view this stock. Truist Securities raised the price target for ServiceNow, Inc. (NYSE:NOW) from $750 to $780. Truist Securities analyst Joel Fishbein maintained a Hold rating. ServiceNow shares gained 11.9% to trade at $817.75 on Thursday. See how other analysts view this stock. JP Morg
Cantor Fitzgerald analyst Sarah James maintains HCA Healthcare (NYSE:HCA) with a Overweight and raises the price target from $335 to $392.
Cantor Fitzgerald analyst Sarah James reiterates HCA Healthcare (NYSE:HCA) with a Overweight and maintains $335 price target.